3,086
Views
11
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis

, , , , &
Pages 229-239 | Received 03 Dec 2020, Accepted 04 Jan 2021, Published online: 27 Jan 2021

References

  • Abdelmonem R, Younis MK, Hassan DH, et al. (2019). Formulation and characterization of chlorhexidine HCl nanoemulsion as a promising antibacterial root canal irrigant: in-vitro and ex-vivo studies. Int J Nanomedicine 14:4697–708.
  • Agrawal KP, Mehta D, Gupta S, Chhabra SK. (1986). Metabolic basis for asthma and rhinitis: an integrated approach. Lung 164:279–91.
  • Akhgari A, Ghalambor Dezfuli A, Rezaei M, Kiarsi M. (2016). Ab- baspour, M. The design and evaluation of a fast-dissolving drug de- livery system for loratadine using the electrospinning method. Jun- Dishapur J. Nat. Pharm. Prod 11:e33613. 33613.
  • Alshehri S, Imam SS, Hussain A, et al. (2020). Flufenamic acid-loaded self-nanoemulsifying drug delivery system for oral delivery: from formulation statistical optimization to preclinical anti-inflammatory assessment. J Oleo Sci 69:1257–71.
  • Azeem A, Rizwan M, Ahmad FJ, et al. (2009). Nanoemulsion components screening and selection: A technical note. AAPS PharmSciTech 10:69–76.
  • Baker RW, Lonsdale H. Controlled release: mechanisms and rates, controlled release of biologically active agents. New York: Plenum Press; 1974; 15–71.
  • Balakumar K, Raghavan CV, selvan NT, et al. (2013). Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation. Colloids Surf B Biointerfaces 112:337–43.
  • Balata GF, Essa EA, Shamardl HA, et al. (2016). Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol. Drug Des Devel Ther 10:117–28.
  • Balata GF. (2018). Formulation and evaluation of gliclazide in vegetable oil-based self emulsifying delivery system. JAPS 8:23–33.
  • Borgaonkar PA, Virsen TG, Hariprasanna RC, Najmuddin M. (2011). Formulation and in vitro evaluation of buccal tablets of loratadine for effective treatment of allergy. Int J Res Pharm Chem 1:551–9.
  • Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group; World Health Organization (2001). Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108:S147–S334.
  • Brustolim D, Ribeiro-dos-Santos R, Kast RE, et al. (2006). A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol 6:903–7.
  • Carbinatto FM, de Castro AD, Evangelista RC, Cury BS. (2014). Insights into the swelling process and drug release mechanisms from cross-linked pectin/high amylose starch matrices. Asian J Pharm Sci 9:27–34. doi:10.1016/j.ajps.2013.12.002
  • Chawla V, Tiwary AK, Gupta S. (2000). Characterization of polyvinylalcohol microspheres of diclofenac sodium: application of statistical design. Drug Dev Ind Pharm 26:675–80.
  • Cottam DR, Mattar SG, Barinas-Mitchell E, et al. (2004 May). The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 14:589–600.
  • Djupesland PG, Messina JC, Mahmoud RA. (2013). Breath powered nasal delivery: a new route to rapid headache relief. Headache 53(Suppl 2):72–84.
  • Fabbri NZ, Abib E, Jr, de Lima Zollner R. (2014). Azelastine and budesonide (nasal sprays): Effect of combination therapy monitored by acoustic rhinometry and clinical symptom score in the treatment of allergic rhinitis. Allergy Rhinol (Providence) 5:78–86.
  • Gaba B, Khan T, Haider MF, et al. (2019). Vitamin E loaded naringenin nanoemulsion via intranasal delivery for the management of oxidative stress in a 6-OHDA Parkinson's disease model. Biomed Res Int 2019:2382563.
  • Gad HA, El-Ahmady SH, Abou-Shoer MI, Al-Azizi MM. (2013). A modern approach to the authentication and quality assessment of thyme using UV spectroscopy and chemometric analysis. Phytochem Anal 24:520–6.
  • Ghosh V, Mukherjee A, Chandrasekaran N. (2013). Ultrasonic emulsification of food-grade nanoemulsion formulation and evaluation of its bactericidal activity. Ultrason Sonochem 20:338–44.
  • Greiner AN, Hellings PW, Rotiroti G, Scadding GK. (2011). Allergic rhinitis. Lancet 378:2112–22.
  • Gurpreet K, Singh SK. (2018). Review of nanoemulsion formulation and characterization techniques. Indian J Pharm Sci 80:781–9.
  • Guttoff M, Saberi AH, McClements DJ. (2015). Formation of vitamin D nanoemulsion-based delivery systems by spontaneous emulsification: factors affecting particle size and stability. Food Chem 171:117–22.
  • Hamaguchi Y, Suzumura H, Arima S, Sakakura Y. (1994). Quantitation and immunocytological identification of interleukin-1 in nasal polyps from patients with chronic sinusitis. Int Arch Allergy Immunol 104:155–9.
  • Hermosilla C, Zahner H, Taubert A. (2006). Eimeria bovis modulates adhesion molecule gene transcription in and PMN adhesion to infected bovine endothelial cells. Int J Parasitol 36:423–31.
  • Higuchi t. (1963). Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–9.
  • Hoeller S, Sperger A, Valenta C. (2009). Lecithin based nanoemulsions: a comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation. Int J Pharm 370:181–6.
  • Illum L. (2002). Nasal drug delivery: new developments and strategies. Drug Discov Today 7:1184–9.
  • Iriyoshi N, Takeuchi K, Yuta A, et al. (1996). Increased expression of histamine H1 receptor mRNA in allergic rhinitis. Clin Exp Allergy 26:379–85.
  • Joung HJ, Choi MJ, Kim JT, et al. (2016). Development of food-grade curcumin nanoemulsion and its potential application to food beverage system: antioxidant property and in vitro digestion. J Food Sci 81:N745–53.
  • Khan K, Aqil M, Imam SS, et al. (2018). Ursolic acid loaded intra nasal nano lipid vesicles for brain tumour: Formulation, optimization, in-vivo brain/plasma distribution study and histopathological assessment. Biomed Pharmacother 106:1578–85.
  • Kim K, Quesada J, Szmaydy-Rikken N, et al. (2007). Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients. J Asthma 44:515–20.
  • Liu Y, Wei F, Wang Y, Zhu G. (2011). Studies on the formation of bifenthrin oil-in-water nano-emulsions prepared with mixed surfactants. Colloids Surf, A 389:90–6. doi:10.1016/j.colsurfa.2011.08.045
  • Maes T, Joos GF, Brusselle GG. (2012). Targeting interleukin-4 in asthma: lost in translation? Am J Respir Cell Mol Biol 47:261–70.
  • Mallick A, Gupta A, Hussain A, et al. (2020). Intranasal delivery of gabapentin loaded optimized nanoemulsion for augmented permeation. JDDST 56:101606. doi:10.1016/j.jddst.2020.101606
  • McClements DJ. (2002). Colloidal basis of emulsion color. Curr Opin Colloid Interface Sci 7:451–5. doi:10.1016/S1359-0294(02)00075-4.
  • McClements DJ. (2002). Theoretical prediction of emulsion color. Adv Colloid Interface Sci 97:63–89.
  • Moffat AC, Osselton MD, Widdop B. (2004) Clarke’s analysis of drugs and poisons, 3rd ed. London: Pharmaceutical Press; 2:1186–1187.
  • Müller RH, Jacobs C, Kayser O. (2001). Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47:3–19. 200.
  • MULLOU J, XAUBET A, GAYA A, et al. (1995). Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy 25:607–15.
  • Ohno I, Lea RG, Flanders KC, et al. (1992). Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest 89:1662–8.
  • Ott LW, Resing KA, Sizemore AW, et al. (2007). Tumor Necrosis Factor-alpha- and interleukin-1-induced cellular responses: coupling proteomic and genomic information. J Proteome Res 6:2176–85. Epub 2007 May 16.
  • Otto BA, Wenzel SE. (2008). The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr Opin Otolaryngol Head Neck Surg 16:270–4.
  • Parul J, Geeta a, SL H, amanpreet K. (2013). Bioavailability enhancdement of poorly soluble drugs by SMEDDS: a review. J Drug Del Ther 3:98–109.
  • Prabhakar K, Afzal SM, Surender G, Kishan V. (2013). Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain. Acta Pharm Sin B 3:345–53.
  • Sagit M, Polat H, Gurgen SG, et al. (2017). Effectiveness of quercetin in an experimental rat model of allergic rhinitis. Eur Arch Otorhinolaryngol 274:3087–95.
  • Samson S, Basri M, Fard Masoumi HR, et al. (2016). Design and development of a nano- emulsion system containing copper peptide by D- optimal mixture design and evaluation of its physico- chemical properties. RSC Adv 6:17845–56.
  • Sari T, Mann B, Kumar R, et al. (2015). Preparation and characterization of nanoemulsion encapsulating curcumin. Food Hydrocolloids 43:540–6. doi:10.1016/j.foodhyd.2014.07.011
  • Sarpal K, Pawar YB, Bansal AK. (2010). Self-emulsifying drug delivery systems: a strategy to improve oral bioavailability. Crips 11:42–9.
  • Senturk E, Yildirim YS, Dogan R, et al. (2018). Assessment of the effectiveness of cyclosporine nasal spray in an animal model of allergic rhinitis. Eur Arch Otorhinolaryngol 275:117–24.
  • Shah VP, Tsong Y, Sathe P, Liu JP. (1998). In vitro dissolution profile comparison–statistics and analysis of the similarity factor, f2. Pharm Res 15:889–96.
  • Sood A, Panchagnula R. (1998). Drug release evaluation of diltiazem CR preparations. Int J Pharm 175:95–107. doi:10.1016/S0378-5173(98)00268-3.
  • Sood S, Jain K, Gowthamarajan K. (2014). Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment. Colloids Surf B Biointerfaces 113:330–7.
  • Sur DK, Scandale S. (2010). Treatment of allergic rhinitis. Am Fam Physician 81:1440–6.
  • Wang XY, Lim-Jurado M, Prepageran N, et al. (2016). Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine. Ther Clin Risk Manag 12:585–97.
  • Xi J, Chang Q, Chan CK, et al. (2009). Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS PharmSciTech 10:172–82.
  • Yao PL, Lin YC, Wang CH, et al. (2005). Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cells. Am J Respir Cell Mol Biol 32:540–7.
  • Zambiazi RC, Przybylski R, Zambiazi MW, Mendonca CB. (2007). Fatty acid composition of vegetable oils and fats. Curitiba 25:111–20.
  • Zhou H, Yue Y, Liu G, et al. (2009). Preparation and characterization of a lecithin nanoemulsion as a topical delivery system. Nanoscale Res Lett 5:224–30. Published 2009 Oct 29.
  • Zidan AS, Emam SE, Shehata TM, Ghazy FE. (2015). Pediatric suppositories of sulpiride solid dispersion for treatment of Tourette syndrome: in vitro and in vivo investigations. AAPS PharmSciTech 16:645–55.